OC
PPH icon

Oarsman Capital’s VanEck Pharmaceutical ETF PPH Stock Holding History

Oarsman Capital’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-200
Closed -$17.3K – 670
2024
Q4 		$17.3K Hold
200
– – ﹤0.01% 621
2024
Q3 		$19K Buy
+200
New +$19K ﹤0.01% 607

Other funds holding PPH

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return

Oarsman Capital's PPH Position: Q1 2025 in Review

Oarsman Capital sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2025, closing a stake of 200 shares — an estimated $17.3K sold.

Oarsman Capital first reported a position in PPH in Q3 2024 and held it in 2 quarters. The position peaked at $19K in Q3 2024. 136 funds tracked by Wall St. Rank hold PPH as of Q1 2025.

  • Oarsman Capital reported no remaining VanEck Pharmaceutical ETF position as of Q1 2025 after selling out during the quarter.
  • Oarsman Capital sold 200 VanEck Pharmaceutical ETF shares in Q1 2025, an estimated $17.3K.
  • Oarsman Capital first reported a position in VanEck Pharmaceutical ETF in Q3 2024 and held it in 2 quarters.
  • Oarsman Capital's VanEck Pharmaceutical ETF position peaked at $19K in Q3 2024.
  • 136 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2025.

Based on Oarsman Capital's 13F filing for Q1 2025, filed 14 May 2025.